口腔治疗难治性ALK阳性炎性肌纤维母细胞瘤
Treatment-refractory ALK-positive inflammatory myofibroblastic tumour of the oral cavity.
作者信息
LaVigne Anna W, Meredith David M, D'Adamo David R, Margalit Danielle N
机构信息
School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
出版信息
BMJ Case Rep. 2018 Apr 11;2018:bcr-2017-221553. doi: 10.1136/bcr-2017-221553.
Abstract
We present a challenging case of a previously healthy 23-year-old man who developed an inflammatory myofibroblastic tumour of the hard palate, harbouring a rearrangement of the anaplastic lymphoma kinase (ALK) locus. Despite surgical intervention, radiotherapy and ALK-inhibition therapy, the tumour recurred locally and metastasised to regional lymph nodes, and the patient passed away roughly 9 months after diagnosis from local progression. The rapid progression of this patient's disease and its resistance to treatment demonstrate the potentially aggressive clinical course of inflammatory myofibroblastic tumours. ALK-inhibition therapy was unsuccessful in this ALK-positive tumour, highlighting the need for further investigation of markers predictive of disease progression and treatment response.
摘要
我们报告了一例具有挑战性的病例，患者为一名23岁既往健康的男性，其硬腭发生了炎性肌纤维母细胞瘤，伴有间变性淋巴瘤激酶（ALK）基因座重排。尽管进行了手术干预、放射治疗和ALK抑制治疗，但肿瘤仍局部复发并转移至区域淋巴结，患者在诊断后约9个月因局部进展而死亡。该患者疾病的快速进展及其对治疗的抵抗性表明炎性肌纤维母细胞瘤可能具有侵袭性的临床病程。ALK抑制治疗对该ALK阳性肿瘤无效，这凸显了进一步研究预测疾病进展和治疗反应的标志物的必要性。
相似文献
1
Treatment-refractory ALK-positive inflammatory myofibroblastic tumour of the oral cavity.口腔治疗难治性ALK阳性炎性肌纤维母细胞瘤
BMJ Case Rep. 2018 Apr 11;2018:bcr-2017-221553. doi: 10.1136/bcr-2017-221553.
2
Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor.克唑替尼治疗间变性淋巴瘤激酶重排的炎性肌纤维母细胞瘤。
N Engl J Med. 2010 Oct 28;363(18):1727-33. doi: 10.1056/NEJMoa1007056.
3
Epithelioid inflammatory myofibroblastic sarcoma treated with ALK inhibitor: a case report and review of literature.用ALK抑制剂治疗上皮样炎性肌纤维母细胞肉瘤：一例报告并文献复习
Int J Clin Exp Pathol. 2015 Nov 1;8(11):15328-32. eCollection 2015.
4
K-RAS mutations indicating primary resistance to crizotinib in ALK-rearranged adenocarcinomas of the lung: Report of two cases and review of the literature.K-RAS突变提示ALK重排的肺腺癌对克唑替尼原发耐药：两例报告及文献复习
Lung Cancer. 2016 Mar;93:55-8. doi: 10.1016/j.lungcan.2016.01.002. Epub 2016 Jan 11.
5
Responses to crizotinib in patients with ALK-positive lung adenocarcinoma who tested immunohistochemistry (IHC)-positive and fluorescence in situ hybridization (FISH)-negative.对免疫组织化学（IHC）呈阳性且荧光原位杂交（FISH）呈阴性的ALK阳性肺腺癌患者使用克唑替尼的反应。
Oncotarget. 2016 Sep 27;7(39):64410-64420. doi: 10.18632/oncotarget.10560.
6
A case report of epithelioid inflammatory myofibroblastic sarcoma with RANBP2-ALK fusion gene treated with the ALK inhibitor, crizotinib.上皮样炎性肌纤维母细胞肉瘤伴 RANBP2-ALK 融合基因病例报告，采用 ALK 抑制剂克唑替尼治疗。
Jpn J Clin Oncol. 2014 Sep;44(9):868-71. doi: 10.1093/jjco/hyu069. Epub 2014 Jul 15.
7
Role of anaplastic lymphoma kinase inhibition in the treatment of non-small-cell lung cancer.间变性淋巴瘤激酶抑制在非小细胞肺癌治疗中的作用
Am J Health Syst Pharm. 2015 Sep 1;72(17):1456-62. doi: 10.2146/ajhp140836.
8
ALK inhibitors in the treatment of advanced NSCLC.ALK 抑制剂治疗晚期 NSCLC。
Cancer Treat Rev. 2014 Mar;40(2):300-6. doi: 10.1016/j.ctrv.2013.07.002. Epub 2013 Aug 7.
9
An Anaplastic Lymphoma Kinase Immunohistochemistry-Negative but Fluorescence In Situ Hybridization-Positive Lung Adenocarcinoma Is Resistant to Crizotinib.间变性淋巴瘤激酶免疫组化阴性但荧光原位杂交阳性的肺腺癌对克唑替尼耐药。
J Thorac Oncol. 2016 Dec;11(12):2248-2252. doi: 10.1016/j.jtho.2016.08.139. Epub 2016 Sep 6.
10
Alectinib versus Crizotinib in Untreated ALK-Positive Non-Small-Cell Lung Cancer.阿来替尼对比克唑替尼用于未经治疗的 ALK 阳性非小细胞肺癌。
N Engl J Med. 2017 Aug 31;377(9):829-838. doi: 10.1056/NEJMoa1704795. Epub 2017 Jun 6.
引用本文的文献
1
Clinicopathological analysis of 18 cases of inflammatory myofibroblastic tumor in oral and maxillofacial region.18例口腔颌面部炎性肌纤维母细胞瘤的临床病理分析
BMC Oral Health. 2025 Apr 18;25(1):591. doi: 10.1186/s12903-025-05995-3.
2
Inflammatory myofibroblastic tumor from molecular diagnostics to current treatment.从分子诊断到当前治疗的炎性肌纤维母细胞瘤。
Oncol Res. 2024 Jun 20;32(7):1141-1162. doi: 10.32604/or.2024.050350. eCollection 2024.
3
Unusual Presentation of Tonsillar Spindle Cell Neoplasm: A Case Report.扁桃体梭形细胞瘤的罕见表现：一例报告
Indian J Otolaryngol Head Neck Surg. 2023 Dec;75(4):3910-3911. doi: 10.1007/s12070-023-03935-7. Epub 2023 Jun 17.
4
Soft Tissue Special Issue: Fibroblastic and Myofibroblastic Neoplasms of the Head and Neck.软组织特刊：头颈部纤维母细胞性和肌纤维母细胞性肿瘤
Head Neck Pathol. 2020 Mar;14(1):43-58. doi: 10.1007/s12105-019-01104-3. Epub 2020 Jan 16.
本文引用的文献
1
Differential Crizotinib Response Duration Among ALK Fusion Variants in ALK-Positive Non-Small-Cell Lung Cancer.ALK 阳性非小细胞肺癌中 ALK 融合变体的克唑替尼反应持续时间差异。
J Clin Oncol. 2016 Oct 1;34(28):3383-9. doi: 10.1200/JCO.2015.65.8732. Epub 2016 Jun 27.
2
Molecular characterization of inflammatory myofibroblastic tumors with frequent ALK and ROS1 gene fusions and rare novel RET rearrangement.具有频繁间变性淋巴瘤激酶（ALK）和ROS1基因融合以及罕见新型RET重排的炎性肌纤维母细胞瘤的分子特征
Am J Surg Pathol. 2015 Jul;39(7):957-67. doi: 10.1097/PAS.0000000000000404.
3
Sinonasal and ventral skull base inflammatory pseudotumor: a systematic review.鼻窦和颅底腹侧炎性假瘤：一项系统综述
Laryngoscope. 2015 Apr;125(4):813-21. doi: 10.1002/lary.24993. Epub 2014 Nov 6.
4
Inflammatory myofibroblastic tumors harbor multiple potentially actionable kinase fusions.炎性肌纤维母细胞瘤含有多种潜在可靶向的激酶融合。
Cancer Discov. 2014 Aug;4(8):889-95. doi: 10.1158/2159-8290.CD-14-0377. Epub 2014 May 29.
5
Uterine inflammatory myofibroblastic tumor in a 10-year-old girl presenting as polypoid mass.一名10岁女孩的子宫炎性肌纤维母细胞瘤，表现为息肉样肿物。
J Clin Oncol. 2015 Jan 10;33(2):e7-e10. doi: 10.1200/JCO.2013.48.8304. Epub 2014 Mar 3.
6
Inflammatory pseudotumor in head and neck.头颈部炎性假瘤
Auris Nasus Larynx. 2014 Jun;41(3):321-4. doi: 10.1016/j.anl.2013.11.002. Epub 2013 Dec 17.
7
Head and neck inflammatory myofibroblastic tumor (IMT): evaluation of clinicopathologic and prognostic features.头颈部炎性肌纤维母细胞瘤（IMT）：临床病理和预后特征评估。
Oral Oncol. 2012 Feb;48(2):141-8. doi: 10.1016/j.oraloncology.2011.09.004. Epub 2011 Oct 19.
8
Epithelioid inflammatory myofibroblastic sarcoma: An aggressive intra-abdominal variant of inflammatory myofibroblastic tumor with nuclear membrane or perinuclear ALK.上皮样炎性肌纤维母细胞肉瘤：一种具有核膜或核周 ALK 的侵袭性腹腔内炎性肌纤维母细胞瘤变体。
Am J Surg Pathol. 2011 Jan;35(1):135-44. doi: 10.1097/PAS.0b013e318200cfd5.
9
Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor.克唑替尼治疗间变性淋巴瘤激酶重排的炎性肌纤维母细胞瘤。
N Engl J Med. 2010 Oct 28;363(18):1727-33. doi: 10.1056/NEJMoa1007056.
10
A successfully treated inflammatory myofibroblastic tumor of the mandible with long-term follow-up and review of the literature.一例成功治疗的下颌骨炎性肌纤维母细胞瘤的长期随访及文献复习
Med Mol Morphol. 2010 Sep;43(3):185-91. doi: 10.1007/s00795-009-0483-6. Epub 2010 Sep 21.
Zotero 插件